U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692295) titled 'Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)' on May 29.
Brief Summary: Antiretroviral therapy (ART) has transformed HIV from a deadly disease into a lifelong infection that can be controlled. Nevertheless, in the majority of people living with HIV (PWH), discontinuation of ART results in viral rebound due to a latent proviral reservoir. Rarely, individuals known as post-treatment controllers (PTC) demonstrate prolonged viral control even after ceasing ART. Investigating the underlying mechanisms driving this sustained viral control has been a goal for the HIV researc...